Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice

Virology

Volumn 240, Issue 1, 1998, Pages 158-167

  Van Der Most, Robbert G ^a   Murali Krishna, Kaja ^b   Whitton, J Lindsay ^c   Oseroff, Carla ^d   Alexander, Jeff ^d   Southwood, Scott ^d   Sidney, John ^d   Chesnut, Robert W ^d   Sette, Alessandro ^d   Ahmed, Rafi ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d CYTEL CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; HLA ANTIGEN CLASS 1; NUCLEOCAPSID PROTEIN; PEPTIDE FRAGMENT; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; VACCINIA VIRUS; VIRUS INFECTION; VIRUS RECOMBINANT; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; CHEMISTRY; CYTOTOXICITY; IMMUNOLOGY; LYMPHOMA; VIRUS MENINGITIS;

ANIMALIA; CHORIOMENINGITIS VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; RNA VIRUSES; VACCINIA; VACCINIA VIRUS;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOMA; MICE; MICE, INBRED C57BL; NUCLEOCAPSID PROTEINS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VIRAL VACCINES;

EID: 0032484298     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8934     Document Type: Article

References (41)

1. Ahmed R., Hahn C. S., Somasundaram T., Villarete L., Matloubian M., Strauss J. H. Molecular basis of organ-specific selection of viral variants during chronic infection. J. Virol. 65:1991;4242-4247.
2. Ahmed R., Salmi A., Butler L. D., Chiller J., Oldstone M. B. A. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persisntently infected mice: Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 60:1984;521-540.
3. Bakker A. B. H., Van der Burgh S. H., Huijbens R. J. F., Drijfhout J. W., Melief C. J. M., Adema G. J., Figdor C. G. Analogs of CTL epitopes with improved MHC class I binding capacity elicit antimelanoma CTL recognizing the wild-type epitope. Int. J. Cancer. 70:1997;302-309.
4. Falk K., Rötzschke O., Stevanovic S., Jung G., Rammensee H. G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC-molecules. Nature. 351:1991;290-296.
5. Feltkamp M. C. W., Vreugdenhil G. R., Vierboom R. P. M., Ras E., van der Burgh S. H., Terschegget J., Melief C. J. M., Kast W. M. Cytotoxic T-lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors. Eur. J. Immunol. 25:1995;2638-2642.
6. b. J. Virol. 69:1995;2297-2305.
7. Hotchin J. Persistent and slow virus infections. Monogr. Virol. 3:1971;1-211.
8. b. J. Biol. Chem. 271:1996;17829-17836.
9. d. Eur. J. Immunol. 22:1992;2663-2667.
10. Kast W. M., Brandt R. M. P., Sidney J., Drijfhout J.-W., Kubo R. T., Grey H. M., Melief C. J. M., Sette A. The role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 152:1994;3904-3912.
11. Kast W. M., Offringa R., Peters P. J., Voordouw A. C., Meloen R. H., Van der Eb A. J., Melief C. J. M. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell. 59:1989;603-614.
12. King C. C., de Fries R., Kolhekar S. R., Ahmed R. In vivo selection of lymphocyte-trophic and macrophage-tropic variants of lymphocytic choriomeningitis virus during persistent infection. J. Virol. 64:1990;5611-5616.
13. Klavinskis L. S., Whitton J. L., Joly E., Oldstone M. B. A. Vaccination and protection from a lethal viral infection: Identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology. 178:1990;393-400.
14. Kubo R. T., Sette A., Grey H. M., Appella E., Sakaguchi K., Zhu N. Z., Arnott D., Sherman N., Shabanowitz J., Michel H., Bodnar W. M., Davis T. A., Hunt D. F. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152:1994;3913-3924.
15. Lau L., Jamieson B. D., Somasundaram T., Ahmed R. Cytotoxic T-cell memory without antigen. Nature. 369:1994;648-652.
16. Mackett M., Smith G. L., Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 49:1984;857-864.
17. Matloubian M., Kolhekar S. R., Somasundaram T., Ahmed R. Molecular determinants of macrophage tropism and viral persistence: Importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 67:1993;7340-7349.
18. Moskophides D., Lechner F., Pircher H., Zinkernagel R. M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector cells. Nature. 362:1993;758-761.
19. Oldstone M. B. A., Lewicki H., Borrow P., Hudrisier D., Gairin J. E. Discriminated selection among viral peptides with the appropriate anchor residues: Implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection. J. Virol. 69:1995;7423-7429.
20. b. J. Exp. Med. 168:1988;559-570.
21. b. J. Immunol. 152:1994;4843-4851.
22. Rammensee H.-G., Friede T., Stevanovic S. MHC ligands and peptide motifs: First listing. Immunogenetics. 41:1995;178-228.
23. Ruppert J., Sidney J., Calls E., Kubo R. T., Grey H. M., Sette A. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell. 74:1993;929-937.
24. Saito Y., Peterson P. A., Matsamura M. Quantitation of peptide anchor residue contributions to class I major histocompatibility complex molecule binding. J. Biol. Chem. 268:1993;21309-21317.
25. Schulz M., Aichele P., Vollenweider M., Bobe F. W., Cardinaux F., Hengartner H., Zinkernagel R. M. Major histocompatibility complex-dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against disease. Eur. J. Immunol. 19:1989;1657-1667.
26. Schumacher T. N. M., De Bruijn M. L. H., Vernie L. N., Kast W. M., Melief C. J. M., Neefjes J. J., Ploegh H. L. Peptide selection by MHC class I molecules. Nature. 350:1991;703-706.
27. Selin L. K., Vergilis K., Welsh R. M., Nahill S. R. Reduction of otherwise remarkebly stable virus-specific cytotoxic T-lymphocyte memory by heterologous viral infections. J. Exp. Med. 183:1996;2489-2499.
28. Sette A., Buus S., Colon S., Miles C., Grey H. M. Structural analysis of peptides capable of binding to more than one IA-antigen. J. Immunol. 42:1989;35-40.
29. Sette A., Sidney J., Del Guercio M.-F., Southwood S., Ruppert J., Dahlberg C., Grey H. M., Tubo R. T. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol. 31:1994;813-822.
30. Sette A., Vitiello A., Reherman B., Fowler P., Nayersina R., Kast W. M., Melief C. J. M., Oseroff C., Yuan L., Ruppert J., Sidney J., Del Guercio M.-F., Southwood S., Kubo R. T., Chesnut R. W., Grey H. M., Chisari F. V. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:1994;5586-5592.
31. Sheng N., Zhang J., Whitton J. L., McKee T. A rapid and simple method for determining the DNA sequences of fragments inserted into vaccinia virus. Biotechniques. 14:1993;781-784.
32. Sidney J., del Guercio M.-F., Southwood S., Engelhard V. H., Appella E., Rammensee H.-G., Falk K., Rotzschke O., Takiguchi M., Kubo R. T., Grey H. M., Sette A. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154:1995;247-259.
33. Tourdot S., Oukka M., Manuguerra J. C., Magafa V., Vergnon I., Riche N., Bruley-Rosset M., Cordopatis P., Kosmatopoulos K. Chimeric peptides: A new approach to enhancing the immunogenicity of peptides with low MHC class I affinity. J. Immunol. 159:1997;2391-2398.
34. Townsend A. R. M., Bodmer H. Antigen recognition by class-I restricted T lymphocytes. Annu. Rev. Immunol. 7:1989;601-624.
35. Van Bleek G. M., Nathenson S. G. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature. 348:1990;213-216.
36. Van der Most R. G., Concepcion R. J., Oseroff C., Alexander J., Southwood S., Sidney J., Chesnut R. W., Ahmed R., Sette A. Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice. J. Virol. 71:1997;5110-5114.
37. Van der Most R. G., Sette A., Oseroff C., Alexander J., Murali-Krishna K., Lau L. L., Southwood S., Sidney J., Chesnut R. W., Matloubian M., Ahmed R. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157:1996;5543-5554.
38. Vitiello A., Ishioka G., Grey H. M., Rose R., Farness P., LaFond R., Yuan L., Chisari F. V., Furze J., Bartholomeuz R., Chesnut R. W. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest. 95:1995;341-349.
39. b. J. Immunol. 157:1996;5555-5562.
40. Whitton J. L., Sheng N., Oldstone M. B. A., McKee T. A. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 67:1993;348-352.
41. Whitton J. L., Southern P. J., Oldstone M. B. A. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology. 162:1988;321-327.